The Efficacy and Safety of Iparomlimab/Tuvonralimab (Anti PD-1/CTLA-4) Combined With Albumin-bound Paclitaxel in Second-line Treatment of Patients With Advanced Gastric/Gastroesophageal Junction Adenocarcinoma

Name: The Efficacy and Safety of Iparomlimab/Tuvonralimab (Anti PD-1/CTLA-4) Combined With Albumin-bound Paclitaxel in Second-line Treatment of Patients With Advanced Gastric/Gastroesophageal Junction Adenocarcinoma
License: Public Domain

Qingxia Li

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

gastric-cancer

gastric cancer, gastroesophageal junction adenocarcinoma

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 127566
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.